Ercros Total Assets
Ercros total assets. Based on the latest financial reports, Ercros (ECR) holds total assets worth €768.68 Million EUR (≈ $898.67 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Ercros for the company's overall valuation and market capitalisation.
Total Assets of Ercros (2000–2025)
Total assets of Ercros from 2000 to 2025. This chart illustrates how Ercros's total assets have evolved over time, based on quarterly financial data. See Ercros (ECR) share price today for real-time trading data and today's change.
Ercros - Asset Composition Analysis
Ercros Total Assets Breakdown (December 2025)
Ercros total assets breakdown as of December 2025. Ercros's total assets of €768.68 Million consist of 35.4% current assets and 64.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.8% |
| Accounts Receivable | €46.48 Million | 6.7% |
| Inventory | €102.15 Million | 14.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €21.28 Million | 3.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Ercros's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ECR working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ercros's current assets represent 35.4% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2025, up from 1.7% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 14.7% of total assets.
Ercros Competitors by Total Assets
Key competitors of Ercros based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Rongsheng Petrochemical Co Ltd
SHE:002493
|
China | CN¥402.82 Billion |
|
Methanex Corporation
TO:MX
|
Canada | CA$7.17 Billion |
|
Sinofibers Technology Co Ltd
SHE:300777
|
China | CN¥4.94 Billion |
|
North Chemical Industries Co Ltd
SHE:002246
|
China | CN¥4.91 Billion |
|
Robertet SA
PA:RBT
|
France | €1.00 Billion |
|
Shanghai Pret Composites
SHE:002324
|
China | CN¥13.10 Billion |
|
Hangzhou Greenda Electronic Materials Co Ltd
SHG:603931
|
China | CN¥2.18 Billion |
|
Yunnan Yunwei Co Ltd Class A
SHG:600725
|
China | CN¥353.34 Million |
Ercros - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 1.50 | 1.25 |
| Quick Ratio | 0.61 | 1.01 | 0.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-4.51 Million | €98.08 Million | €48.02 Million |
Ercros - Advanced Valuation Insights
This section examines the relationship between Ercros's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.46 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | €694.30 Million |
| Market Capitalization | $319.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ercros's assets below their book value (0.46x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Ercros's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Ercros (2000–2025)
The table below shows the annual total assets of Ercros from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €694.30 Million ≈ $811.71 Million |
-0.70% |
| 2024-12-31 | €699.19 Million ≈ $817.43 Million |
+2.32% |
| 2023-12-31 | €683.32 Million ≈ $798.87 Million |
-8.47% |
| 2022-12-31 | €746.55 Million ≈ $872.80 Million |
+5.15% |
| 2021-12-31 | €709.96 Million ≈ $830.01 Million |
+20.29% |
| 2020-12-31 | €590.22 Million ≈ $690.03 Million |
-10.08% |
| 2019-12-31 | €656.41 Million ≈ $767.42 Million |
+8.22% |
| 2018-12-31 | €606.57 Million ≈ $709.15 Million |
+1.23% |
| 2017-12-31 | €599.17 Million ≈ $700.50 Million |
+6.96% |
| 2016-12-31 | €560.18 Million ≈ $654.91 Million |
+9.48% |
| 2015-12-31 | €511.68 Million ≈ $598.21 Million |
-1.74% |
| 2014-12-31 | €520.72 Million ≈ $608.78 Million |
-7.72% |
| 2013-12-31 | €564.29 Million ≈ $659.71 Million |
-6.76% |
| 2012-12-31 | €605.18 Million ≈ $707.52 Million |
-0.06% |
| 2011-12-31 | €605.56 Million ≈ $707.96 Million |
-3.37% |
| 2010-12-31 | €626.69 Million ≈ $732.67 Million |
-2.09% |
| 2009-12-31 | €640.10 Million ≈ $748.34 Million |
-9.47% |
| 2008-12-31 | €707.03 Million ≈ $826.59 Million |
-25.50% |
| 2007-12-31 | €949.03 Million ≈ $1.11 Billion |
-5.64% |
| 2006-12-31 | €1.01 Billion ≈ $1.18 Billion |
+32.03% |
| 2005-12-31 | €761.81 Million ≈ $890.64 Million |
+110.52% |
| 2004-12-31 | €361.87 Million ≈ $423.06 Million |
+2.35% |
| 2003-12-31 | €353.55 Million ≈ $413.34 Million |
+3.94% |
| 2002-12-31 | €340.14 Million ≈ $397.66 Million |
+0.68% |
| 2001-12-31 | €337.84 Million ≈ $394.97 Million |
-99.41% |
| 2000-12-31 | €56.93 Billion ≈ $66.56 Billion |
-- |
About Ercros
Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl ch… Read more